Skip to content

Prospective Randomized Controlled Clinical Study for Heart Health Beverage in Preventing Radiotherapy-related Cardiac Diseases in Breast Cancer

Prospective Randomized Controlled Clinical Study for Heart Health Beverage in Preventing Radiotherapy-related Cardiac Diseases in Breast Cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023226
Enrollment
Unknown
Registered
2019-05-17
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

experimental group:heart health beverage

Sponsors

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Willingness to sign the written informed consent document. 2. Female patients aged between 18 and 70 years with left side of breast cancer, Karnofsky performance score =70 points; 3. Breast cancer who has indication to receive adjuvant radiotherapy (50Gy/25Fx); 4. Pathological confirm of invasive breast cancer with negative surgical margin; 5. Patients received Cardiotoxic drugs in adjuvant or neoadjuvant stage; 6. Cardiac function: all of the patients were required to have a left ventricular ejection fraction (LVEF) >50%; 7. Patients had a life expectancy of 12 months or more.

Exclusion criteria

Exclusion criteria: 1. Disatant metastasis; 2. Right side of breast cancer; 3. T1-2N0, received Mastectomy 4. History of cardiac disease; 5. Hepatic functionalanine aminotransferase (ALT) and aspartate aminotransferase(AST)>2×ULN; 6. Severe or uncontrolled infection; 7. Women who are pregnant, breastfeeding; 8. History of other malignant disease; 9. Drug allergy to study drug; 10. Enrolled in other clinical trials; 11. History of Thoracic Radiotherapy.

Design outcomes

Primary

MeasureTime frame
Myocardial enzymes;cardiac function;

Secondary

MeasureTime frame
QOL;OS;

Countries

China

Contacts

Public ContactXu Cheng

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine

xucheng60@126.com+86 021-64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026